For R&D use only.

GSK-256066

  • Catalog NO.:A839850
  • CAS No. : 801312-28-7
  • Molecular Formula:C27H26N4O5S
  • Molecular Weight: 518.58
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS

Product Details

CAS Number 801312-28-7 Appearance
Catalog Number A839850 MDL Number MFCD18206923
Molecular Formula C27H26N4O5S Molecular Weight 518.58
Boiling Point 791.7±60.0°C at 760 mmHg Melting Point
Flash Point Density
Synonyms 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide;GSK256066
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements H315-H319-H335 Class
Precautionary Statements P261-P305+P351+P338 Packing Group

Description

GSK256066 is a potent and selective PDE4 inhibitor that can be given by inhalation, minimising the potential for side effects. GSK256066 demonstrated a protective effect on the EAR and LAR. GSK256066 is a slow and tight binding inhibitor of PDE4B (apparent IC(50) 3.2 pM; steady-state IC(50) <0.5 pM), which is more potent than any previously documented compound, for example, roflumilast (IC(50) 390 pM), tofimilast (IC(50) 1.6 nM), and cilomilast (IC(50) 74 nM). Consistent with this, GSK256066 inhibited tumor necrosis factor α production by lipopolysaccharide (LPS)-stimulated human peripheral blood monocytes with 0.01 nM IC(50). GSK256066 has been demonstrated to have exceptional potency in vitro and in vivo and is being clinically investigated as a treatment for chronic obstructive pulmonary disease.

801312-28-7 (free base)

801315-14-0 (HCl)

1415560-64-3 (TFA)

Related Products

My Tracks: GSK-256066
Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

GSK-256066
6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide;GSK256066